| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a3febfbd930318f2b7418da1deddb9a |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2035-122 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-454
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0646
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-17 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06 |
| filingDate |
2020-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_139e17179c58b14088fee41e53f76c0c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc0b6360336e3ff1a51ceff0db432081
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b2b9dfec188bf54aeb6f8f3a0d48d5a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f43a18ee8dbd15ea227214f97ff024aa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b0a4a2daebce23d574af8db32bacd02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a723adfe4b2679bbc8df006bee1561dc |
| publicationDate |
2020-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2020196724-A |
| titleOfInvention |
Placenta-derived natural killer cells |
| abstract |
PROBLEM TO BE SOLVED: To suppress the growth of a tumor cell or treat a graft-versus-host disease using a natural killer cell, the growth of the natural killer cell culture and growth without reducing the tumor targeting ability, the tumor killing ability and the like. Providing new methods that can be applied to suppression and treatment. A method of suppressing the growth of tumor cells, which comprises contacting the tumor cells with natural killer cells isolated from human placental perfusate and cord blood. A method of treating graft-versus-host disease in which natural killer cells isolated from human placental perfusate and cord blood have graft-versus-host disease or are suspected of having graft-versus-host disease. Alternatively, the method comprising administering to a patient at risk of developing graft-versus-host disease. [Selection diagram] Fig. 1 |
| priorityDate |
2013-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |